What Is Happening to Medicine

Abstract

What is happening to medicine? Are the dictums of Standard of Care outweighing the needs of those who are to be served? I think so. Take, for instance, the screening recommendations for prostate cancer. The USPSTF concluded several years ago, 2012 I believe, that screening for men younger than 75 “offered no benefit” to that age group. Insufficient evidence was their language. And if someone is over 75, then they recommend totally against screening. I have read the background to these recommendations. There have been extensive studies, those with PSA, those without PSA who get DRE (digital rectal exams). It is remarkable, really, that this has been the position for over half a decade by the preventative task force. But it is a challenge when in your training the 70’s and 80’s, through medical school, internship and residency, palpating the prostate and later the blood analyses (there are multiple ones now) was an integral part of examining men. Well there is another area that seems to me less clear, and that is the standards for tick bites in areas where Lyme disease is endemic. Currently the recommendations are no treatment at all if the tick is not engorged, and one day (maybe) if the tick IS engorged. Now granted, a tick bite does not confer the diagnosis of Lyme disease to the individual. But in endemic areas, where 60% of the ticks are infected with Borrelia burgderfori, it might be a consideration to treat someone preventatively. Not to mention that over 20% of those infected never recall a tick bite. Not to mention that doctors give prescriptions for doxycycline for years for individuals with cystic acne. So what is the thinking? I was bitten recently by a tick, saw it tightly attached under my right arm, and called my wife. We have a tick spoon remover, and used it. It felt like a phlebotomy. But the whole darn thing was removed, and I was pretty certain it was new, ie, within the last 10 or 12 hours. So I called the clinic for a week of doxycycline. “Can I get it?” “No,” was the answer initially from the nurse. “Let me talk to the doctor.” I get a call back a few hours later and was asked if the tick were engorged. “No” I replied. Well then, no treatment will be given….well, maybe one dose of 200 mg of doxycycline.I responded by mentioning the above facts, and was ignored since giving a week of doxycycline for a tick bite is not the standard of care. Amazing, I thought. So, I called the pharmacy and prescribed the week of antibiotics for myself….and took it….along with three refills just in case.

Authors and Affiliations

Douglas Trenkle

Keywords

Related Articles

Botryoid Odontogenic Cyst with Extensive Clear Cells

Botryoid odontogenic cysts (BOC) is an unusual multi cystic variant of the lateral periodontal cyst. We report a case of BOC in a 29-year-old male patient. Radiographic examination revealed a multi locular radiolucency f...

Rare Presentations of Metastatic Renal Cell Carcinoma with Hematochezia and Anemia

Renal cell carcinoma (RCC) is the sixth most common cancer in men and the eighth most common cancer in women in the United States, with an estimated 65,150 new cases diagnosed in 2013 [1]. RCC’s classic presenting triad...

Regulation of PD-L1 Expression by Histone Deacetylase Inhibitor SAHA in Lung Cancer Cells

The expression of PD-L1 is checkpoint indicator indicative of immunosuppression and cause for poor prognosis in several cancers. The effects of PD-L1 are mediated through its binding to the Programmed Cell Death-1 (PD-1)...

Syringomyelia in the Thoracolumbar Spinal Cord of an African Wild Dog (Lycaon Pictus)

A captive born neonatal African wild dog (Lycaon pictus) exhibited hind limb weakness and ataxia since the onset of ambulation. Initial examination at one month of age revealed postural reaction deficits in both hind leg...

The Mаximum Stаndаrdized Fdg Uptаke on Pet-Ct in Pаtients with Smаll Cell Lung Cаncer

Bаckground: Smаll-cell lung cаncer (SCLC) accounts for 15%–20% of аll lung cаncer cаses. PET-CT hаs become increasingly used as an initial staging tool in pаtients with SCLC. PET hаs emerged in the lаst decаde аs аn impo...

Download PDF file
  • EP ID EP569510
  • DOI 10.26717/BJSTR.2017.01.000243
  • Views 149
  • Downloads 0

How To Cite

Douglas Trenkle (2017). What Is Happening to Medicine. Biomedical Journal of Scientific & Technical Research (BJSTR), 1(3), 556-556. https://europub.co.uk/articles/-A-569510